Article Data

  • Views 477
  • Dowloads 139

Case Reports

Open Access

Ovarian tumors: Should the cervix be examined first

  • G.M. Makris1,*,
  • C. Chrelias1
  • A. Papanota1
  • M.J. Battista2
  • N. Papantoniou1

1Gynecological Oncology Unit, Third Department of Obstetrics and Gynecology, General University Hospital “Attikon”, University of Athens, Athens, Greece

2Department of Gynecology and Obstetrics, University Hospital Mainz, Mainz, Germany

DOI: 10.12892/ejgo3530.2017 Vol.38,Issue 3,June 2017 pp.462-464

Published: 10 June 2017

*Corresponding Author(s): G.M. Makris E-mail: makrismg@hotmail.com

Abstract

There is a controversy regarding ovarian metastasis in early-stage adenocarcinoma of the uterine cervix. The authors present the case of a 51-year-old woman that at the time of diagnosis was thought to suffer from a Stage II cervical carcinoma and a synchronous ovarian carcinoma, that turned out to be an ovarian metastasis from the endocervical adenocarcinoma, as attested morphologically, histochemically, and immunohistochemically. Radical hysterectomy with oophorectomy, excision of the omentum, lymph node excision, and cytological sampling of the peritoneal cavity were carried out. It is important to always bear in mind that even low-grade adenocarcinomas of the cervix can be metastatic to the ovaries. Clinicians have to be careful when managing those cases, while further investigation is needed in order to determine the exact mechanism of those metastases and the criteria needed in order to preserve the ovaries in young patients.

Keywords

Ovarian metastasis; Endocervical adenocarcinoma; Fertility-sparing surgery.

Cite and Share

G.M. Makris,C. Chrelias,A. Papanota,M.J. Battista,N. Papantoniou. Ovarian tumors: Should the cervix be examined first. European Journal of Gynaecological Oncology. 2017. 38(3);462-464.

References

[1] Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M.: “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”. Int. J. Cancer, 2010, 127, 2893.

[2] Kane M.A.: “Preventing cancer with vaccines: progress in the global control of cancer”. Cancer Prev. Res. (Phila.), 2012, 5, 24.

[3] Colombo N., Carinelli S., Colombo A., Marini C., Rollo D., Sessa C., et al.: “Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Ann. Oncol., 2012, 23, vii27.

[4] Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P., et al.: “Carcinoma of the cervix uteri. 25th volume of the FIGO Annual Report on the results of treatment of gynecological cancer”. Int. J. Gynaecol. Obstet., 2003, 83, 41.

[5] Mc C.M., Keaty E.C., Thompson J.D.: “Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery”. Am. J. Obstet. Gynecol., 1958, 75, 590.

[6] Mann W.J., Chumas J., Amalfitano T., Westermann C., Patsner B.: “Ovarian metastases from stage IB adenocarcinoma of the cervix”. Cancer, 1987, 60, 1123.

[7] Nakanishi T., Wakai K., Ishikawa H., Nawa A., Suzuki Y., Nakamura S., et al.: “A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix”. Gynecol. Oncol., 2001, 82, 504.

[8] Parham G., Heppard M.C., DiSaia P.J.: “Metastasis from a stage IB cervical adenocarcinoma in a transposed ovary: a case report and review of the literature”. Gynecol. Oncol., 1994, 55, 469.

[9] Natsume N., Aoki Y., Kase H., Kashima K., Sugaya S., Tanaka K.: “Ovarian metastasis in stage IB and II cervical adenocarcinoma”. Gynecol. Oncol., 1999, 74, 255.

[10] Tabata M., Ichinoe K., Sakuragi N., Shiina Y., Yamaguchi T., Mabuchi Y.: “Incidence of ovarian metastasis in patients with cancer of the uterine cervix”. Gynecol. Oncol., 1987, 28, 255.

[11] Abdulhathi M.B., Al-Salam S., Kassis A., Ghazal-Aswad S.: “Unusual presentation of cervical cancer as advanced ovarian cancer”. Arch. Gynecol. Obstet., 2007, 276, 387.

[12] Khor T.S., Brennan B.A., Leung Y.C., Sengupta S., Stewart C.J.: “Cervical adenocarcinoma metastatic to the ovary mimicking primary ovarian carcinoma”. Pathology, 2009, 41, 397.

[13] Kaminski P.F., Norris H.J.: “Coexistence of ovarian neoplasms and endocervical adenocarcinoma”. Obstet. Gynecol., 1984, 64, 553.

[14] Wu H.S., Yen M.S., Lai C..R, Ng H.T.: “Ovarian metastasis from cervical carcinoma”. Int. J. Gynaecol. Obstet., 1997, 57, 173.

[15] Shimada M., Kigawa J., Nishimura R., Yamaguchi S., Kuzuya K., Nakanishi T., et al.: “Ovarian metastasis in carcinoma of the uterine cervix”. Gynecol. Oncol., 2006, 101, 234.

[16] Landoni F., Zanagnolo V., Lovato-Diaz L., Maneo A., Rossi R., Gadducci A., et al.: “Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)”. Int. J. Gynecol. Cancer, 2007, 17, 623.

[17] Hu T., Wu L., Xing H., Yang R., Li X., Huang K., et al.: “Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis”. Ann. Surg. Oncol., 2013, 20, 881.

[18] Touhami O., Plante M.: “Should ovaries be removed or not in (earlystage) adenocarcinoma of the uterine cervix: a review”. Gynecol. Oncol., 2015, 136, 384.

[19] Vang R., Gown A.M., Barry T.S., Wheeler D.T., Ronnett B.M.: “Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases”. Mod. Pathol., 2006, 19, 97.

[20] Wentzensen N., du Bois A., Kommoss S., Pfisterer J., von Knebel Doeberitz M., Schmidt D., et al.: “No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group”. Int. J. Gynecol. Pathol., 2008, 27, 18.

[21] Giordano G., Azzoni C., D’Adda T., Rocco A., Gnetti L., Froio E., et al.: “Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms”. Pathol. Res. Pract., 2008, 204, 163.

[22] Anttila M., Syrjanen S., Ji H., Saarikoski S., Syrjanen K.: “Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR”. Gynecol. Oncol., 1999, 72, 337.

[23] Leake J.F., Woodruff J.D., Searle C., Daniel R., Shah K.V., Currie J.L.: “Human papillomavirus and epithelial ovarian neoplasia”. Gynecol. Oncol., 1989, 34, 268.

[24] Pirog E.C., Kleter B., Olgac S., Bobkiewicz P., Lindeman J., Quint W.G., et al.: “Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma”. Am. J. Pathol., 2000, 157, 1055.

[25] Vang R., Gown A.M., Farinola M., Barry T.S., Wheeler D.T., Yemelyanova A., et al.: “p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas”. Am. J. Surg. Pathol., 2007, 31, 653.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top